Study Title
ALTE03N1: Key Adverse Events After Childhood Cancer
Protocol ID
ALTE03N1
Condition/s
Childhood Malignant Neoplasm
Diagnosis Stage
Previously treated
Location
QLD, WA, SA
Sponsor
Children's Oncology Group
Collaborators
National Cancer Institute (NCI)
Links
Trial Status
Closed to Recruitment
Trial Close Date
28/02/2025
Sites
Women's & Children's Hospital
Queensland Children's Hospital
Perth Children's Hospital
Queensland Children's Hospital
Perth Children's Hospital
Study Type
Observational
Phase
Not applicable
Age Eligibility
up to 21 Years
International registry ID's
NCT00082745
| Study Title | ALTE03N1: Key Adverse Events After Childhood Cancer |
|---|---|
| Protocol ID | ALTE03N1 |
| Disease (Sub Disease) | Childhood Malignant Neoplasm |
| Diagnosis Stage | Previously treated |
| Location | QLD / WA / SA |
| Sponsor | Children's Oncology Group |
| Collaborators | National Cancer Institute (NCI) |
| Links | https://clinicaltrials.gov/ct2/show/NCT00082745 |
| Trial Status | Closed to Recruitment |
| Trial Open Date | 24/03/2004 |
| Trial Close Date | 28/02/2025 |
| Sites | Women's & Children's Hospital / Queensland Children's Hospital/ Perth Children's Hospital |
| Study Type | Observational |
| Phase | Not applicable |
| Age Eligibility | up to 21 Years |
| International registry ID's | NCT00082745 |